Getting it right the first time.
1 in 5
biopsies taken in the US fail to return a diagnosis. We at MedKairos believe that
we should do everything in our power to ensure that we are providing the best care possible for our patients without the premium price tag.
We will shape the future of digital pathology, one biopsy at a time.
The Growing Divide
As cancer rate rise in the United States, there is a projected 25% decrease in the pathology labor force in the next 10 years
The time is now
Introducing Bioptic™ – guaranteed samples in seconds